Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration

Human Gene Therapy

Volumn 8, Issue 1, 1997, Pages 37-44

  Worgall, Stefan ^a   Wolff, Gerhard ^a   Falck Pedersen, Erik ^b   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; VIRUS DNA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE TRANSFER; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LIVER; MOUSE; NONHUMAN; VIRUS GENOME; VIRUS IMMUNITY;

EID: 0031034030     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.1-37     Document Type: Article

References (45)

1. ARMENTANO, D., SOOKDEO, C.C., HEHIR, K.M., GREGORY, R.J., ST GEORGE, J.A., PRINCE, G.A., WADSWORTH, S.C., and SMITH, A.E. (1995). Characterization of an adenovirus gene transfer vector containing an E4 deletion. Hum. Gene Ther. 6, 1343-1353.
2. BARR, D., TUBB, J., FERGUSON, D., SCARIA, A., LIEBER, A., WILSON, C., PERKINS, J., and KAY, M.A. (1995). Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2, 151-155.
3. CRYSTAL, R.G. (1995). Transfer of genes to humans: Early lessons and obstacles to success. Science 270, 404-410.
4. CRYSTAL, R.G., MCELVANEY, N.G., ROSENFELD, M.A., CHU, C.S., MASTRANGELI, A., HAY, J.G., BRODY, S.L., JAFFE, H.A., EISSA, N.T., and DANEL, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8, 42-51.
5. DAI, Y., SCHWARZ, E.M., GU, D., ZHANG, W-W., SARVETNICK, M., and VERMA, I.M. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405.
6. DUNCAN, S.J., GORDON F.C., GREGORY, D.W., MCPHIE, J.L., POSTLETHWAITE, R., WHITE, R., and WILLCOX, H.N. (1978). Infection of mouse liver by human adenovirus type 5. J. Gen. Virol. 40, 45-61.
7. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
8. FEARON, D.T., and LOCKSLEY, R.M. (1996). The instructive role of innate immunity in the acquired immune response. Science 272, 50-54.
9. GRAHAM, F.L., and PREVEC, L. (1991). Manipulation of adenovirus vectors. In Methods in Molecular Biology. E.J. Murray, ed. (The Humana Press, Clifton, NY) pp. 109-128.
10. HERZ, J., and GERARD, R.D. (1993). Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol in normal mice. Proc. Natl. Acad. Sci. USA 90, 2812-2816.
11. HORWITZ, M.S. (1990). Adenoviridae and their replication. In Virology. B.N. Fields and D.M. Knipe, eds. (Raven Press, New York) pp. 1679-1740.
12. HUANG, S., ENDO, R.I., and NEMEROW, G.R. (1995). Upregulation of integrins alpha V beta 3 and alpha V beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J. Virol. 69, 2257-2263.
13. HUARD, J., LOCHMULLER, H., ACSADI, G., JANI, A., MASSIE, B., and KARPATI, G. (1995). The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 2, 107-115.
14. JAFFE, H.A., DANEL, C., LONGENECKER, G., METZGER, M., SETOGUCHI, Y., ROSENFELD, M.A., GANT, T.W., THORGEIRSSON, S.S., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., PAVIRANI, A., LECOCQ, J.-P., and CRYSTAL, R.G. (1992). Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1, 372-378.
15. KASS-EISLER, A., FALCK-PEDERSEN, E., ALVIRA, M., RIVERA, J., BUTTRICK, P.M., WITTENBERG, B.A., CIPRIANI, L., and LEINWAND, L.A. (1993). Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc. Natl. Acad. Sci. USA 90, 11498-11502.
16. KASS-EISLER, A., FALCK-PEDERSEN, E., ELFENBEIN, D.H., ALVIRA, M., BUTTRICK, P.M., and LEINWAND, L.A. (1994). The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1, 395-402.
17. KAY, M.A., HOLTERMAN, A.X., MEUSE, L., GOWN, A., OCHS, H.D., LINSLEY, P.S., and WILSON, C.B. (1995). Long-term hepatic adenovirus-mediated gene expression in mice following CTLA41g administration. Nature Genet. 11, 191-197.
18. KOPFLER, W.P., WILLARD, M., BETZ, T., WILLARD, J.E., GERARD, R.D., and MEIDELL, R.S. (1994). Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol. Circulation 90, 1319-1327.
19. - adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector. Gene Ther. 2, 256-262.
20. LI, Q., KAY, M.A., FINEGOLD, M., STRATFORD-PERRICAUDET, L.D., and WOO, S.L.C. (1993). Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4, 403-409.
21. MARRACK, P., and KAPPLER, J. (1994). Subversion of the immune system by pathogens. Cell 76, 323-332.
22. MASTRANGELI, A., HARVEY, B.-G., YAO, J., WOLFF, G., KOVESDI, I., and CRYSTAL, R.G. (1996). "Sero-switch" adenovirus-mediated in vivo gene transfer: Circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype. Hum. Gene Ther. 7, 79-87.
23. MILLER, S.A., DYKES, D.D., and POLESKY, H.F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16, 1215.
24. MULLBACHER, A., BELLETT, A.J., and HLA, R.T. (1989). The murine cellular immune response to adenovirus type 5. Immunol. Cell. Biol. 67, 31-39.
25. POSTLETHWAITE, R. (1973). Liver damage induced in mice by human adenovirus type 5. Scot. Med. J. 18, 131.
26. ROSENFELD, M.A., SIEGFRIED, W., YOSHIMURA, K., YONEYAMA, K., FUKAYAMA, M., STIER, L.E., PAAKKO, P.K., GILARDI, P., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., JALLAT, S., PAVIRANI, A., LECOCQ, J., and CRYSTAL, R.G. (1991). Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252, 431-434.
27. ROSENFELD, M.A., YOSHIMURA, K., TRAPNELL, B.C., YONEYAMA, K., ROSENTHAL, E.R., DALEMANS, W., FUKAYAMA, M., BARGON, J., STIER, L.E., STRATFORD-PERRICAUDET, L., PERRICAUDET, M., GUGGINO, W.B., PAVIRANI, A., LECOCQ, J.-P., and CRYSTAL, R.G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
28. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
29. SETOGUCHI, Y., JAFFE, H.A., CHU, C.S., and CRYSTAL, R.G. (1994). Intraperitoneal in vivo gene therapy to deliver alpha 1-anti-trypsin to the systemic circulation. Am. J. Respir. Cell. Mol. Biol. 10, 369-377.
30. SMITH, T.A.G., MEHAFFEY, M.G., KAYDA, D.B., SAUNDERS, J.M., YEI, S., TRAPNELL, B.C., McCLELLAND, A., and KALEKO, M. (1993). Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet. 5, 397-402.
31. TENG, B., BLUMENTHAL, S., FORTE, T., NAVARATNAM, N., SCOTT, J., GOTTO, A.M., JR., and CHAN, L. (1994). Adenovirus-mediated gene transfer of rat apolipoprotein b mRNA-editing protein in mice virtually eliminates apolipoprotein b-100 and normal low density lipoprotein production. J. Biol. Chem. 269, 29395-29404.
32. VAN GINKEL, F.W., LIU, C., SMIECKA, J.W., DONG, J.-Y., GREENWAY, T., FRIZZELL, R.A., KIYONO, H., MCGHEE, J.R., and PASCUAL, D.W. (1995). Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and β-galactosidase. Hum. Gene Ther. 6, 895-903.
33. WOLD, W.S., HERMISTON, T.W., and TOLLEFSON, A.E. (1994). Adenovirus proteins that subvert host defenses. Trends Microbiol. 2, 437-443.
34. + CTLs in vivo. J. Immunol. 155, 2564-2570.
35. YANG, Y., ERTL, H.C., and WILSON, J.M. (1994a). MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1, 433-442.
36. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994b). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
37. YANG, Y., NUNES, F.A., BERENCSI, K., BONCZOL, E., ENGELHARDT, J.F., and WILSON, J.M. (1994c). Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7, 362-369.
38. YANG, Y., LI, Q., ERTL, H.C.J., and WILSON, J.M. (1995a). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
39. YANG, Y., TRINCHIERI, G., and WILSON, J.M. (1995b). Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med. 1, 890-893.
40. YANG, Y., XIANG, Z., ERTL, H.C., and WILSON, J.M. (1995c). Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92, 7257-7261.
41. YEI, S., MITTEREDER, N., TANG, K., O'SULLIVAN, C., and TRAPNELL, B.C. (1994). Adenovirus-mediated gene transfer to cystic fibrosis: Quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1, 192-200.
42. ZABNER, J., PETERSEN, D.M., PUGA, A.P., GRAHAM, S.M., COUTURE, L.A., KEYES, L.D., LUKASON, M.J., ST. GEORGE, J.A., GREGORY, R.J., SMITH, A.E., and WELSH, M.J. (1994). Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nature Genet. 6, 75-83.
43. ZINKERNAGEL, R.M. (1993). Immunity of viruses. In Fundamental Immunology. W.E. Paul, ed. (Raven Press, New York) pp. 1211-1250.
44. ZISMAN, B., WHEELOCK, E.F., and ALLISON, A.C. (1971). Role of macrophages and antibody in resistance of mice against yellow fever virus. J. Immunol. 107, 236-243.
45. ZSENGELLER, Z.K., WERT, S.E., HULL, W.M., HU, X., YEI, S., TRAPNELL, B.C., and WHITSETT, J.A. (1995). Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6, 457-467.